Actinium Pharmaceuticals, Inc. (ATNM)

Deferred Revenue

$0.00

Quarterly · Period ending: · USD

ATNM logo

ATNM Deferred Revenue

Latest reported$0.00
ATNM Quarterly Deferred Revenue ($0.00 → $0.00)
High-resolution chart · PNG

ATNM deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Actinium Pharmaceuticals, Inc. Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
0
0
35,000,000
35,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-5,130,710
-4,700,582
-5,317,871
-6,063,243
0
0
0
0
0
0
0
0
0
85,154
25,000
25,000
0
25,000
307,912
214,357
0
189,537
189,537
81,185
0
31,185
31,185
31,185
0
0
0
-124,363
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.